Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The …
Medical - Diagnostics & Research
US, Washington [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -30.92 | 103.89 | 150.38 | |
| Graham Fair Price | 0.27 | 48.84 | 48.71 | |
| PEG | 615.85 | 62.04 | -8.67 | |
| Price/Book | 8.15 | 3.46 | 3.20 | |
| Price/Cash Flow | -9.18 | 127.72 | 140.63 | |
| Prices/Earnings | 7.17 | 42.50 | 39.65 | |
| Price/Sales | -49.79 | 31.91 | 63.55 | |
| Price/FCF | -9.18 | 127.72 | 140.63 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Bad
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -0.17 | 0.60 | 0.60 | |
| Operating Margin | 12.68 | 0.23 | 0.20 | |
| ROA | 2.15 | 0.01 | 0.01 | |
| ROE | 0.02 | 0.02 | 0.92 | |
| ROIC | < 0.005 | 0.02 | 77.77 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.01 | -0.11 | 87.79 | |
| Dividends QOQ | 2.15 | -0.72 | -66.59 | |
| EBIT QOQ | -0.62 | 1.43 | 128.47 | |
| EPS QOQ | -0.05 | < 0.005 | -85.03 | |
| FCF QOQ | -0.07 | 0.19 | 175.65 | |
| Revenue QOQ | -0.61 | 1.15 | 89.46 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Balanced
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 218.19 | 103.10 | -52.75 | |
| Days Sales Outstanding (DSO) | 131.07 | 52.47 | -59.97 | |
| Inventory Turnover | 0.41 | 0.87 | 111.63 | |
| Debt/Capitalization | 0.27 | 0.26 | -0.97 | |
| Quick Ratio | 1.18 | 1.34 | 13.16 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 72.30 | 72.16 | -0.19 | |
| Cash | 7.93 | 9.49 | 19.77 | |
| Capex | -0.54 | -0.39 | 27.69 | |
| Free Cash Flow | 1.65 | 1.96 | 18.85 | |
| Revenue | 3.64 | 7.83 | 114.99 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Best
Fundamentals
Financial Health
06 - Financial Health ·
Weak